Israeli health- care providers plan to start testing the population for coronavirus antibodies this week in an attempt to discover how many Israelis have developed immunity to the virus, Israeli media reported on Sunday.

Depending on the results, large segments of the population could potentially not have to worry about being quarantined or isolated and could fly or rejoin the workforce without any restrictions, according to Ynet.

Last week it was reported that Israel was planning to conduct 100,000 serological tests for COVID-19 as part of its efforts to determine just how widespread the disease was. Israel has purchased 2.4 million test kits to this end, and once the Health Ministry deems the tests effective, the first to get tested, on a voluntary basis, will be at-risk populations, including medical staff and the elderly, according to the report.

Meanwhile, the government is expanding the aid program to deal with the coronavirus crisis from NIS 80 billion ($22.8 billion) to NIS 100 billion ($28.5 billion), the Israeli Finance Ministry announced on Friday.

To accomplish this the government will have to amend the country’s Basic Law: The State Economy, which requires a Knesset majority, according to a report on Sunday by the Israeli business daily Globes. To finance the program, Israel’s fiscal deficit will have to exceed 10.2 percent of GDP, which it was already expected to reach by the end of the year.

The new funds will go to increasing employment and to at-risk businesses. In addition, funds will be used for infrastructure projects, including the digitization of public services, online health services, and assistance for small businesses, according to the report.

Support Jewish Journalism
with 2020 Vision

One of the most intriguing stories of the sudden Coronavirus crisis is the role of the internet. With individuals forced into home quarantine, most are turning further online for information, education and social interaction.

JNS's influence and readership are growing exponentially, and our positioning sets us apart. Most Jewish media are advocating increasingly biased progressive political and social agendas. JNS is providing more and more readers with a welcome alternative and an ideological home.

During this crisis, JNS continues working overtime. We are being relied upon to tell the story of this crisis as it affects Israel and the global Jewish community, and explain the extraordinary political developments taking place in parallel.

Our ability to thrive in 2020 and beyond depends on the generosity of committed readers and supporters. Monthly donations in particular go a long way in helping us sustain our operations. We greatly appreciate any contributions you can make during these challenging times. We thank you for your ongoing support and wish you blessings for good health and peace of mind.